InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,447.87
(
-0.31%
)
US TECH 100
19,051.60
(
0.49%
)
Dow Jones
39,411.21
(
0.67%
)
Brent Oil
84.84
(
-0.50%
)
Bitcoin
61,238.52
(
1.62%
)

Replies to post #70879 on Ayala Pharmaceuticals Inc (ADXS)

Replies to #70879 on Ayala Pharmaceuticals Inc (ADXS)

ignatiusrielly35

06/11/18 2:05 PM

#70884 RE: dafreaks #70879

The reasoning on Amgen's part (and often the baby bio's part) is that they do not want the financial terms of one development deal to effect the negotiation of deals with other companies.